Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
$49.00
Provider: Stock Traders Daily
$20.00
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Accretive Health Inc provides restatement update


Wednesday, 12 Mar 2014 08:00am EDT 

Accretive Health Inc:Says following discussions with its independent auditors, it has determined that although its work associated with its financial restatement is substantially complete, it has taken longer than anticipated and more time is needed.Says as a result, it will not be in a position to complete its financial restatement by the previously disclosed March 19, New York Stock Exchange (NYSE) deadline to file its Annual Report on Form 10-K with the Securities and Exchange Commission (SEC).Says it is currently in the process of working with its auditors to complete the audits as soon as possible. 

Company Quote

8.15
 --
26 Nov 2014